IDiyas

For the Inventor, By the Inventor

Niantic, CT, United States of America

Clifford N Meltz

USPTO Granted Patents = 9 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Gales Ferry, CT (US) (1987 - 1989)
  • Niantic, CT (US) (2003 - 2007)

Company Filing History:

goldMedal9 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1987-2007

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7176315 - Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer (2007-02-13),
2. 6740757 - ENANTIOMERS OF 6-[(4-CHLORO-PHENYL)-HYDROXY-(3-METHYL-3H-IMIDAZOL-4-YL)-METHYL]-4-[3-(3-HYDROXY-3-METHYL-BUT-1-YNYL)-PHENYL]-1-METHYL-1H-QUINOLIN-2-ONE AND SALTS THEREOF, USEFUL IN THE TREATMENT OF CANCER (2004-05-25),
3. 6734308 - Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3,- dihydroxybutanedioate salts and method of production (2004-05-11),
4. 6673929 - Process for preparing growth hormone secretagogues (2004-01-06),
5. 6645982 - Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production (2003-11-11),
6. 6541634 - Process for preparing growth hormone secretagogues (2003-04-01),
7. 4821802 - Aqueous sulfomethylated melamine gel-forming compositions and methods of (1989-04-18),
8. 4772641 - Aqueous sulfomethylated melamine gel-forming compositions (1988-09-20),
9. 4708974 - Enhanced hydrocarbon recovery by permeability modification with phenolic (1987-11-24),

Title: The Innovative Contributions of Clifford N Meltz

Introduction

Clifford N Meltz is a notable inventor based in Niantic, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds useful in the treatment of cancer. With a total of 9 patents to his name, Meltz's work exemplifies the intersection of innovation and healthcare.

Latest Patents

Meltz's latest patents focus on the enantiomers of a specific compound, 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one. This invention is particularly relevant for its application in treating hyperproliferative diseases, such as cancers, in mammals. The patent details processes for producing enantiomerically pure or optically enriched forms of the compound using continuous chromatography. Additionally, it discusses the use of L-(+)-tartaric acid or (S)-(−)-1,1'-binapthyl-2,2'-diyl hydrogenphosphate salts of the compound.

Career Highlights

Meltz is currently associated with Pfizer Corporation, a leading pharmaceutical company known for its innovative research and development. His work at Pfizer has allowed him to contribute to groundbreaking advancements in cancer treatment.

Collaborations

Meltz has collaborated with notable colleagues, including Derek Lawrence Tickner and Ping W Chang. These partnerships have further enhanced the scope and impact of his research.

Conclusion

Clifford N Meltz's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight the importance of innovation in healthcare. His patents and collaborations reflect a commitment to advancing medical science for the benefit of patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…